These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32620648)

  • 1. Synchronous Primary Pancreatic Ductal Carcinoma and Colonic Adenocarcinoma Present in a Patient With History of Skin Squamous Cell Carcinoma.
    Cao C; Parikh P; Moezardalan K; Anantharaman A; Azarm A; Lai J
    Anticancer Res; 2020 Jul; 40(7):4029-4032. PubMed ID: 32620648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous Pancreatic Ductal Adenocarcinoma and Hepatocellular Carcinoma: Report of a Case and Review of the Literature.
    Lai JZ; Zhou Y; Cao D
    Anticancer Res; 2018 May; 38(5):3009-3012. PubMed ID: 29715132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous Pancreatic Ductal Adenocarcinoma and Nasopharyngeal Carcinoma With Associated Novel Pathogenic ATM Mutation.
    Xu L; Tian A; Fan R; Lai J
    Anticancer Res; 2024 Oct; 44(10):4605-4608. PubMed ID: 39348969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response in
    Campoverde LE; Batalini F; Bulushi Y; Bullock A
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35487638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic drainage for management of infected necrosis following EUS-TA in a patient with pancreatic cancer: A case report.
    Kim YJ; Cho E; Park CH
    Medicine (Baltimore); 2021 Apr; 100(16):e25466. PubMed ID: 33879679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
    Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
    Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion Surgery for Metastatic Pancreatic Mucinous Carcinoma Responsive to Systemic Chemotherapy with Modified FOLFIRINOX: A Case Report.
    Yokoyama T; Makino H; Hirakata A; Ueda J; Takata H; Okusa M; Kawashima M; Tsujino T; Hosone M; Matsushita A; Nakamura Y; Yoshida H
    J Nippon Med Sch; 2019 Dec; 86(5):284-290. PubMed ID: 31105119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation.
    Neyaz A; Tabb ES; Shih A; Zhao Q; Shroff S; Taylor MS; Rickelt S; Wo JY; Fernandez-Del Castillo C; Qadan M; Hong TS; Lillemoe KD; Ting DT; Ferrone CR; Deshpande V
    Histopathology; 2020 Jul; 77(1):35-45. PubMed ID: 32031712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report.
    Shimmura H; Kuramochi H; Jibiki N; Katagiri S; Nishino T; Araida T
    Jpn J Clin Oncol; 2019 Dec; 49(11):1049-1054. PubMed ID: 31612916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma.
    Muroni M; D'Angelo F; Pezzatini M; Sebastiani S; Noto S; Pilozzi E; Ramacciato G
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):97-9. PubMed ID: 20133238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous regression of pancreatic cancer with liver metastases.
    Saade Lemus P; Anderson K; Smith M; Bullock A
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
    Cao C; Kong MX; Kapali M; Moezardalan K; Shi Q; Azarm A; Lai J
    Anticancer Res; 2020 Aug; 40(8):4401-4404. PubMed ID: 32727769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment.
    Vuijk FA; de Muynck LDAN; Franken LC; Busch OR; Wilmink JW; Besselink MG; Bonsing BA; Bhairosingh SS; Kuppen PJK; Mieog JSD; Sier CFM; Vahrmeijer AL; Verheij J; Fariňa-Sarasqueta A; Swijnenburg RJ
    Sci Rep; 2020 Oct; 10(1):16211. PubMed ID: 33004930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
    Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
    Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
    Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
    Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostics and therapy of pancreatic carcinoma].
    Wenzel P; von Figura G
    Dtsch Med Wochenschr; 2021 Feb; 146(4):246-252. PubMed ID: 33592660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma.
    Meijer LL; Garajová I; Caparello C; Le Large TYS; Frampton AE; Vasile E; Funel N; Kazemier G; Giovannetti E
    Ann Surg; 2020 Jun; 271(6):1137-1147. PubMed ID: 30394883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis.
    Choi JG; Nipp RD; Tramontano A; Ali A; Zhan T; Pandharipande P; Dowling EC; Ferrone CR; Hong TS; Schrag D; Fernandez-Del Castillo C; Ryan DP; Kong CY; Hur C
    Oncologist; 2019 Jul; 24(7):945-954. PubMed ID: 30559125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy.
    Goong HJ; Moon JH; Choi HJ; Lee YN; Choi MH; Kim HK; Lee TH; Cha SW
    Gut Liver; 2015 Sep; 9(5):685-8. PubMed ID: 26087782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.